Hereditary thrombocythemia due to splicing donor site mutation of THPO in a Japanese family

Ann Hematol. 2024 Jan;103(1):89-96. doi: 10.1007/s00277-023-05523-9. Epub 2023 Nov 14.

Abstract

Thrombopoietin (THPO) is an essential factor for platelet production. Hereditary thrombocythemia (HT) is caused by a germline mutation of THPO, MPL, or JAK2 and is inherited in an autosomal-dominant manner. We identified a Japanese family with HT due to a point mutation of the splicing donor site of the THPO gene (THPO c.13 + 1G > A). Bone marrow biopsy showed increased megakaryocytes mimicking essential thrombocythemia. One affected family member developed chronic myeloid leukemia. We cloned the mutation and developed mutated and wild type THPO expression vectors. Molecular analysis showed that the mutation causes an exon 3 skipping transcript of THPO that abrogates a suppressive untranslated upstream open reading frame. Although the transcript levels of THPO mRNA were comparable, mutated transcripts were more efficiently translated and THPO protein expression was significantly higher than that of the wild type.

Keywords: Congenital thrombocytosis; Exon skipping; Hereditary thrombocythemia; Thrombopoietin.

MeSH terms

  • Humans
  • Japan
  • Mutation
  • Thrombocytosis* / genetics
  • Thrombopoietin* / genetics

Substances

  • CAMTA2 protein, human
  • Thrombopoietin